EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 128 filers reported holding EPIZYME INC in Q2 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $917,000 | -58.4% | 797,000 | -9.6% | 0.00% | -60.0% |
Q4 2021 | $2,205,000 | -74.9% | 882,000 | -48.6% | 0.01% | -75.0% |
Q3 2021 | $8,778,000 | -1.2% | 1,714,500 | +60.4% | 0.02% | 0.0% |
Q2 2021 | $8,883,000 | +20.3% | 1,068,900 | +26.1% | 0.02% | +5.3% |
Q1 2021 | $7,381,000 | -10.7% | 847,400 | +11.4% | 0.02% | -13.6% |
Q4 2020 | $8,263,000 | +51.6% | 760,900 | +66.5% | 0.02% | +29.4% |
Q3 2020 | $5,451,000 | – | 456,904 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |